Table 3. Prevalence of BCP A1762T/G1764A and PC G1896A mutants.
| HBV characteristics | No. (%) | mean ± SD | Pvalue |
|---|---|---|---|
| PC | |||
| W(G1896) | 29 (50.0) | 0 | |
| M (A1896) | 29 (50.0) | 13.9 ± 17.9 | |
| Genotype C | 18 (62.1) | 13.3 ± 18.2 | *0.8154 |
| Genotype B | 11 (37.9) | 14.9 ± 18.3 | |
| BCP | |||
| W (A1762/G1764) | 23 (39.7) | 0 | |
| M (T1762/A1764) | 35 (60.3) | 54.1 ± 42.9/56.2 ± 44.0 | |
| Genotype C | 29 (80.6) | 58.1 ± 42.5/60.8 ± 43.6 | *>0.05 |
| Genotype B | 7 (19.4) | 38.2 ± 44.2/37.8 ± 44.0 | |
| Combinations (1762/1764/1896) | |||
| W/W/W (A/G/G) | 10 (17.2) | 0/0/0 | |
| W/W/M (A/G/A) | 13 (22.4) | 0/0/18.4 ± 24.0 | |
| M/M/W (T/A/G) | 19 (32.8) | 69.3 ± 42.8/68.8 ± 43.3/0 | |
| M/M/M (T/A/A) | 16 (27.6) | 36.1 ± 36.7/41.3 ± 41.4/10.3 ± 10.4 | <0.05 |
*T- test of mutant percentages between genotype C and genotype B. W: wild type; M: mutant type